AH
Alexandria Hammond B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
89bio
ETNB
$1.28B
| $8.65 | $29 |
235%
upside
| Buy |
25 Aug ‘25
17 days ago |
|
2
Akero Therapeutics
AKRO
$3.59B
| $44.93 | $64 |
42%
upside
| Buy |
27 May ‘25
3 months ago |
|
3
Regeneron Pharmaceuticals
REGN
$60.2B
| $568.20 | $1,150 |
102%
upside
| Outperform |
15 Nov ‘24
10 months ago |
|
4
Pfizer
PFE
$141B
| $24.86 | $25 |
1%
upside
| Underperform |
15 Nov ‘24
10 months ago |
|
5
Moderna
MRNA
$9.88B
| $25.39 | $40 |
58%
upside
| Underperform |
15 Nov ‘24
10 months ago |
|
6
Eli Lilly
LLY
$678B
| $756.28 | $1,000 |
32%
upside
| Outperform |
15 Nov ‘24
10 months ago |
|
7
Johnson & Johnson
JNJ
$430B
| $178.50 | $190 |
6%
upside
| Outperform |
15 Nov ‘24
10 months ago |
|
8
Gilead Sciences
GILD
$146B
| $117.86 | $110 |
7%
downside
| Outperform |
15 Nov ‘24
10 months ago |
|
9
AbbVie
ABBV
$389B
| $220.22 | $205 |
7%
downside
| Outperform |
15 Nov ‘24
10 months ago |
|
10
Madrigal Pharmaceuticals
MDGL
$9.79B
| $439.45 | $150 |
66%
downside
| Underperform |
22 Apr ‘24
1 year ago |
|